Hospital Research on Social Anxiety Seeks Study Participants
New Britain [March 31 2006] -
Anxiety disorders are among the most common mental illnesses in the U.S., affecting 40 million, or 18 percent, of the adult population.
The Psychiatry and Behavioral Health Research Center at New Britain General Hospital is currently studying an investigational medication for social anxiety.
If you or a family member are living with social anxiety you may be eligible to participate. Eligibility criteria vary, but generally, participants should be between the ages of 18 and 65, and in generally good health.
The goal is to determine the efficacy of a new medication for treatment of social anxiety. Participants will receive a complete physical and full blood work-up, various therapies and possibly new medications, all at no cost.
Social anxiety disorder (Social Phobia), is characterized by an intense fear of social or performance situations. Individuals with the disorder are acutely aware of the physical signs of their anxiety and fear that others will notice and think poorly of them. This fear often results in extreme anxiety in anticipation of an activity. Adults often recognize that their fears are excessive, but still suffer.
One benefit of participating in clinical research is that participants may try new medications and/or treatments before they are made available to the general public. In addition, research staff function as an extended support system for participants by listening, educating, and providing resources along the way. Study participants also have the opportunity to contribute to the development of treatments for their conditions that may help others in the future.
In addition to receiving treatment at no cost, participants are reimbursed for their time, meals, and transportation. The principal investigator, Michael Balkunas, MD, chief of psychiatry at New Britain General, has been treating patients with social anxiety disorder for more than 10 years. For more information, please call Alison Oville, psychiatry research manager, at 860-224-5597.
Contact: Corporate Communications, 860-224-5900 x6507
HCC Corporate Communications
(860) 224-5695 •
Fax (860) 224-5779